
Michael Thanh Tran
Examiner (ID: 128, Phone: (571)272-1795 , Office: P/2827 )
| Most Active Art Unit | 2827 |
| Art Unit(s) | 2818, 2511, 2827 |
| Total Applications | 3169 |
| Issued Applications | 2956 |
| Pending Applications | 141 |
| Abandoned Applications | 104 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11323845
[patent_doc_number] => 20160354457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'INJECTABLE VACCINES AGAINST MULTIPLE MENINGOCOCCAL SEROGROUPS'
[patent_app_type] => utility
[patent_app_number] => 15/240385
[patent_app_country] => US
[patent_app_date] => 2016-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19362
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15240385
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/240385 | Injectable vaccines against multiple meningococcal serogroups | Aug 17, 2016 | Issued |
Array
(
[id] => 13049333
[patent_doc_number] => 10046043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-14
[patent_title] => GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by
[patent_app_type] => utility
[patent_app_number] => 15/237495
[patent_app_country] => US
[patent_app_date] => 2016-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 25952
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15237495
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/237495 | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by | Aug 14, 2016 | Issued |
Array
(
[id] => 11400482
[patent_doc_number] => 20170021020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'MONOCLONAL ANTIBODY AND VACCINE TARGETING FILAMENTOUS BACTERIOPHAGE'
[patent_app_type] => utility
[patent_app_number] => 15/219073
[patent_app_country] => US
[patent_app_date] => 2016-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6956
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15219073
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/219073 | MONOCLONAL ANTIBODY AND VACCINE TARGETING FILAMENTOUS BACTERIOPHAGE | Jul 24, 2016 | Abandoned |
Array
(
[id] => 14102839
[patent_doc_number] => 20190093095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => BOTULINUM TOXIN-HUMAN EPIDERMAL GROWTH FACTOR FUSION PROTEIN WITH INCREASED SKIN CELL PROLIFERATION AND ANTI-OXIDATION EFFECT AND COSMETIC COMPOSITION FOR REGENERATING SKIN AND IMPROVING SKIN WRINKLE COMPRISING THE SAME AS EFFECTIVE COMPONENT
[patent_app_type] => utility
[patent_app_number] => 15/522160
[patent_app_country] => US
[patent_app_date] => 2016-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522160
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/522160 | Botulinum toxin-human epidermal growth factor fusion protein with increased skin cell proliferation and anti-oxidation effect and cosmetic composition for regenerating skin and improving skin wrinkle comprising the same as effective component | Jul 21, 2016 | Issued |
Array
(
[id] => 11554224
[patent_doc_number] => 20170100471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'MENINGOCOCCAL MULTIVALENT NATIVE OUTER MEMBRANE VESICLE VACCINE, METHODS OF MAKING AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/208067
[patent_app_country] => US
[patent_app_date] => 2016-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12291
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15208067
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/208067 | MENINGOCOCCAL MULTIVALENT NATIVE OUTER MEMBRANE VESICLE VACCINE, METHODS OF MAKING AND USE THEREOF | Jul 11, 2016 | Abandoned |
Array
(
[id] => 13311423
[patent_doc_number] => 20180207248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => COMPOSITIONS AND METHODS FOR MODULATING AND/OR STIMULATING IMMUNE RESPONSES IN HUMAN AND/OR ANIMAL
[patent_app_type] => utility
[patent_app_number] => 15/741832
[patent_app_country] => US
[patent_app_date] => 2016-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13708
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741832
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/741832 | Compositions and methods for modulating and/or stimulating immune responses in human and/or animal | Jul 10, 2016 | Issued |
Array
(
[id] => 16815782
[patent_doc_number] => 11000582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-11
[patent_title] => Proteins and immunizing compositions containing
[patent_app_type] => utility
[patent_app_number] => 15/741574
[patent_app_country] => US
[patent_app_date] => 2016-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 39
[patent_no_of_words] => 31979
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741574
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/741574 | Proteins and immunizing compositions containing | Jul 7, 2016 | Issued |
Array
(
[id] => 15420727
[patent_doc_number] => 10543266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides
[patent_app_type] => utility
[patent_app_number] => 15/741669
[patent_app_country] => US
[patent_app_date] => 2016-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9594
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741669
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/741669 | Polysaccharide vaccine formulations and processes for industrial production of bacterial polysaccharides | Jul 3, 2016 | Issued |
Array
(
[id] => 15130097
[patent_doc_number] => 10478485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-19
[patent_title] => Methods and compositions to prevent or treat bacterial infections
[patent_app_type] => utility
[patent_app_number] => 15/741069
[patent_app_country] => US
[patent_app_date] => 2016-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 8129
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15741069
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/741069 | Methods and compositions to prevent or treat bacterial infections | Jun 30, 2016 | Issued |
Array
(
[id] => 12886297
[patent_doc_number] => 20180187274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => LACTOBACILLUS PARACASEI FOR THE PRODUCTION OF CONJUGATED LINOLEIC ACID, NUTRITIONAL AND PHARMACEUTICAL PREPARATIONS CONTAINING IT AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/738889
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15738889
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/738889 | LACTOBACILLUS PARACASEI FOR THE PRODUCTION OF CONJUGATED LINOLEIC ACID, NUTRITIONAL AND PHARMACEUTICAL PREPARATIONS CONTAINING IT AND USES THEREOF | Jun 29, 2016 | Abandoned |
Array
(
[id] => 13091215
[patent_doc_number] => 10064932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Integration of meningococcal conjugate vaccination
[patent_app_type] => utility
[patent_app_number] => 15/197376
[patent_app_country] => US
[patent_app_date] => 2016-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10710
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15197376
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/197376 | Integration of meningococcal conjugate vaccination | Jun 28, 2016 | Issued |
Array
(
[id] => 13049331
[patent_doc_number] => 10046042
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-14
[patent_title] => Meningococcal conjugate vaccine for groups A, C, Y and W135 and a preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 15/197369
[patent_app_country] => US
[patent_app_date] => 2016-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9019
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15197369
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/197369 | Meningococcal conjugate vaccine for groups A, C, Y and W135 and a preparation method thereof | Jun 28, 2016 | Issued |
Array
(
[id] => 14746825
[patent_doc_number] => 20190256586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTION OF MALARIA BIOMARKERS
[patent_app_type] => utility
[patent_app_number] => 15/736838
[patent_app_country] => US
[patent_app_date] => 2016-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15736838
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/736838 | Compositions and methods for detection of malaria biomarkers | Jun 16, 2016 | Issued |
Array
(
[id] => 13397605
[patent_doc_number] => 20180250345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-06
[patent_title] => VEGFR-2 TARGETING DNA VACCINE FOR COMBINATION THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/737659
[patent_app_country] => US
[patent_app_date] => 2016-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11935
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737659
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737659 | VEGFR-2 targeting DNA vaccine for combination therapy | Jun 15, 2016 | Issued |
Array
(
[id] => 11704654
[patent_doc_number] => 20170173153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST CANDIDIASIS'
[patent_app_type] => utility
[patent_app_number] => 15/180794
[patent_app_country] => US
[patent_app_date] => 2016-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10901
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15180794
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/180794 | PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST CANDIDIASIS | Jun 12, 2016 | Abandoned |
Array
(
[id] => 12814138
[patent_doc_number] => 20180163216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => GENE EXPRESSION IN BACTEROIDES
[patent_app_type] => utility
[patent_app_number] => 15/580859
[patent_app_country] => US
[patent_app_date] => 2016-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580859
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/580859 | Gene expression in Bacteroides | Jun 9, 2016 | Issued |
Array
(
[id] => 12786421
[patent_doc_number] => 20180153976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => NOVEL CMV PP65 TARGETING DNA VACCINE FOR CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 15/737679
[patent_app_country] => US
[patent_app_date] => 2016-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737679 | NOVEL CMV PP65 TARGETING DNA VACCINE FOR CANCER IMMUNOTHERAPY | Jun 5, 2016 | Abandoned |
Array
(
[id] => 15264853
[patent_doc_number] => 20190381160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => PERSONALIZED DELIVERY VECTOR-BASED IMMUNOTHERAPY AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/576178
[patent_app_country] => US
[patent_app_date] => 2016-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -104
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15576178
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/576178 | PERSONALIZED DELIVERY VECTOR-BASED IMMUNOTHERAPY AND USES THEREOF | May 25, 2016 | Abandoned |
Array
(
[id] => 12238482
[patent_doc_number] => 20180071346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'ANTICARIOGENIC AGENT AND ANTICARIOGENIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/560375
[patent_app_country] => US
[patent_app_date] => 2016-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7770
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560375
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/560375 | ANTICARIOGENIC AGENT AND ANTICARIOGENIC COMPOSITION | May 23, 2016 | Abandoned |
Array
(
[id] => 16913952
[patent_doc_number] => 20210187044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => LACTIC ACID BACTERIA CAPABLE OF CONTROLLING BLOOD SUGAR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/303401
[patent_app_country] => US
[patent_app_date] => 2016-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303401
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/303401 | LACTIC ACID BACTERIA CAPABLE OF CONTROLLING BLOOD SUGAR AND USE THEREOF | May 23, 2016 | Abandoned |